B. Brandt

发表

Immunologic response of man to group B meningococcal polysaccharide vaccines.

D. Kasper, D L Kasper, M. Artenstein, 1972, The Journal of infectious diseases.

Immunological relationship between the capsular polysaccharides of Neisseria meningitidis serogroups Z and 29E.

J. Griffiss, B. Brandt, 1983, Journal of general microbiology.

Immunogenicity of Intranasally Administered Meningococcal Native Outer Membrane Vesicles in Mice

B. Brandt, W. Zollinger, N. B. Saunders, 1999, Infection and Immunity.

Structural and Immunochemical Characterization of the Lipooligosaccharides Expressed by Neisseria subflava 44

B. Reinhold, D. Stein, V. Reinhold, 2001, Journal of bacteriology.

, Brenda 44 Neisseria subflava Lipooligosaccharides Expressed by Characterization of the Structural and Immunochemical

B. Reinhold, D. Stein, V. Reinhold, 2000 .

Safety and immunogenicity of multiple conventional immunizations administered during early HIV infection.

R. Redfield, D. Burke, D. Birx, 1991, Journal of acquired immune deficiency syndromes.

Effects of multiple freeze thaws and various temperatures on the reactivity of human immunodeficiency virus antibody using three detection assays.

D. Burke, B. Brandt, J. Damato, 1988, Journal of virological methods.

Antibody-dependent mononuclear cell-mediated antimeningococcal activity. Comparison of the effects of convalescent and postimmunization immunoglobulins G, M, and A.

R. Macdermott, J. Griffiss, B. Brandt, 1980, The Journal of clinical investigation.

Structural Relationships and Sialylation among Meningococcal L1, L8, and L3,7 Lipooligosaccharide Serotypes*

J. Griffiss, B. Brandt, W. Zollinger, 2000, The Journal of Biological Chemistry.

Design and evaluation in mice of a broadly protective meningococcal group B native outer membrane vesicle vaccine.

Ping Chen, M. Stoddard, B. Brandt, 2010, Vaccine.

Phase I study of a Neisseria meningitidis liposomal vaccine containing purified outer membrane proteins and detoxified lipooligosaccharide.

G. Matyas, C. Alving, B. Brandt, 2012, Vaccine.

Immunogenicity and Safety Testing of a Group B Intranasal Meningococcal Native Outer Membrane Vesicle Vaccine

B. Brandt, W. Zollinger, R. Katial, 2002, Infection and Immunity.

Immunochemical similarity between polysaccharide antigens of Escherichia coli 07: K1(L):NM and group B Neisseria meningitidis.

D. Kasper, J. Winkelhake, M. Artenstein, 1973, Journal of immunology.

Production and Degradation of Serogroup B Neisseria meningitidis Polysaccharide

P. Maloney, B. Brandt, H. Schneider, 1972, Infection and immunity.

Antibody responses in serum and nasal secretions of children immunized with inactivated and attenuated measles-virus vaccines.

J. Bellanti, M. Artenstein, B. Brandt, 1969, The New England journal of medicine.

A radioactive antigen-binding assay for Neisseria meningitidis polysaccharide antibody.

M. Artenstein, F. Wyle, B. Brandt, 1972, Journal of immunology.

Safety and immunogenicity testing of an intranasal group B meningococcal native outer membrane vesicle vaccine in healthy volunteers.

J. Drabick, B. Brandt, W. Zollinger, 1999, Vaccine.

Immunologic hyporesponsiveness in man to group C meningococcal polysaccharide.

M. Artenstein, B. Brandt, Malcolm S. Artenstein, 1975, Journal of immunology.

Safety and immunogenicity of a group 29E meningococcal capsular polysaccharide vaccine in adults

G. Pier, J. Griffiss, B. Brandt, 1983, Infection and immunity.

Safety and immunogenicity of group Y and group W135 meningococcal capsular polysaccharide vaccines in adults

G. Pier, J. Griffiss, B. Brandt, 1981, Infection and immunity.

Immunogenicity of serogroup A and C Neisseria meningitidis polysaccharide vaccines administered together in humans.

M. Artenstein, B. Brandt, C. Smith, 1978, The Journal of infectious diseases.

Relationship of dose to the reactogenicity and immunogenicity of meningococcal polysaccharide vaccines in adults.

J. Griffiss, B. Brandt, P. Altieri, 1985, Military medicine.

Immune response of infants and children to disseminated infections with Neisseria meningitidis.

J. Griffiss, C. Baker, B. Brandt, 1984, The Journal of infectious diseases.

Human immune response to various doses of group Y and W135 meningococcal polysaccharide vaccines

J. Griffiss, B. Brandt, D. D. Broud, 1982, Infection and immunity.

Serologic studies of meningococcal infection and polysaccharide vaccination.

M. Artenstein, B. Brandt, E. Tramont, 1971, The Journal of infectious diseases.

Expression of the L8 lipopolysaccharide determinant increases the sensitivity of Neisseria meningitidis to serum bactericidal activity

B. Brandt, W. Zollinger, E. Moran, 1994, Infection and immunity.

Characterization of Native Outer Membrane Vesicles from lpxL Mutant Strains of Neisseria meningitidis for Use in Parenteral Vaccination

Ping Chen, M. Fisseha, B. Brandt, 2005, Infection and Immunity.

Safety and immunogenicity testing of an intranasal group B Meningocococcal native outer membrane vesicle vaccine in healthy yplnntPPire

J. Drabick, B. Brandt, W. Zollinger, 1999 .

Diagnosis of Human Immunodeficiency Virus Infection by Immunoassay Using a Molecularly Cloned and Expressed Virus Envelope Polypeptide: Comparison to Western Blot on 2707 Consecutive Serum Samples

R. Redfield, D. Burke, T. H. Lee, 1987 .

Evidence of serum antibodies to Neisseria gonorrhoeae before gonococcal infection.

C. Hicks, J. Boslego, B. Brandt, 1987, The Journal of infectious diseases.

Duration of antibody responses after vaccination with group C Neisseria meningitidis polysaccharide.

M. Artenstein, B. Brandt, 1975, The Journal of infectious diseases.

Large-volume air sampling for Meningococci and Adenoviruses.

M. Artenstein, B. Brandt, W. S. Miller, 1968, American journal of epidemiology.

Expression oftheL8Lipopolysaccharide Determinant Increases theSensitivity ofNeisseria meningitidis toSerumBactericidal Activity

B. Brandt, W. Zollinger, E. Moran, 1994 .

Immunological and Molecular Characterization of Three Variant Subtype P1.14 Strains of Neisseria meningitidis

R. Warren, B. Brandt, W. Zollinger, 1998, Infection and Immunity.

Meningococcal serogroup B vaccine protection trial and follow-up studies in Chile. The Chilean National Committee for Meningococcal Disease.

J. Boslego, B. Brandt, W. Zollinger, 1991, NIPH annals.

Safety and antigenicity studies of a polyvalent meningococcal protein-polysaccharide vaccine

J. Boslego, B. Brandt, W. Zollinger, 1986, Antonie van Leeuwenhoek.

Antigenic specificity of bactericidal antibodies in antisera to Neisseria meningitidis.

D. Kasper, J. Winkelhake, M. Artenstein, 1973, The Journal of infectious diseases.

Elaboration of both the group W135 and group Y capsular polysccharides by a single strain of Neisseria meningitidis.

G. Pier, J. Griffiss, B. Brandt, 1980, Journal of general microbiology.

IgA-dependent, monocyte-mediated, antibacterial activity

J. Griffiss, B. Brandt, G. Lowell, 1980, The Journal of experimental medicine.

Human bactericidal antibody response to meningococcal outer membrane protein vaccines

J. Boslego, B. Brandt, W. Zollinger, 2004, Antonie van Leeuwenhoek.

Response of children to Neisseria meningitidis polysaccharide vaccines.

A. Monto, M. Artenstein, B. Brandt, 1973, The Journal of infectious diseases.

FLUORESCENT-ANTIBODY STUDIES OF THE MYCELIAL FORM OF HISTOPLASMA CAPSULATUM AND MORPHOLOGICALLY SIMILAR FUNGI

L. Kaufman, B. Brandt, 1964, Journal of bacteriology.

EVALUATION OF THE FLUORESCENT ANTIBODY AND AGAR GEL PRECIPITIN TESTS FOR DETECTING HISTOPLASMA ANTIBODIES IN ANTICOMPLEMENTARY SERA.

L. Kaufman, B. Brandt, D. Mclaughlin, 1964, American journal of hygiene.

Immunoglobulin responses in serum and nasal secretions after natural adenovirus infections.

J. Bellanti, E. Buescher, M. Artenstein, 1969, Journal of immunology.

Antibody Responses to Meningococcal Polysaccharide Vaccines

M. Artenstein, B. Brandt, C. Smith, 1973, Infection and immunity.

Disease due to serogroup W135 Neisseria meningitidis.

J. Griffiss, B. Brandt, 1979, Pediatrics.

Importance of Antibodies to Lipopolysaccharide in Natural and Vaccine-Induced Serum Bactericidal Activity against Neisseria meningitidis Group B

B. Brandt, W. Zollinger, P. Keiser, 2011, Infection and Immunity.

Safety andImmunogenicity ofaGroup29EMeningococcal Capsular Polysaccharide Vaccine inAdults

G. Pier, J. Griffiss, B. Brandt, 1983 .

Confirmation of suspicious cases of meningococcal meningitis by PCR and enzyme-linked immunosorbent assay

B. Brandt, W. Zollinger, N. B. Saunders, 1997, Journal of clinical microbiology.

Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile. Chilean National Committee for Meningococcal Disease.

J. Boslego, B. Brandt, W. Zollinger, 1995, Vaccine.

Intranasal Delivery of Group B Meningococcal Native Outer Membrane Vesicle Vaccine Induces Local Mucosal and Serum Bactericidal Antibody Responses in Rabbits

B. Brandt, W. Zollinger, N. B. Saunders, 2005, Infection and Immunity.

Monoclonal antibodies to serotype 2 and serotype 15 outer membrane proteins of Neisseria meningitidis and their use in serotyping

R. Mandrell, B. Brandt, W. Zollinger, 1984, Infection and immunity.